Washington - The U.S. Food and Drug Administration (FDA) has granted marketing approval for Aldara (imiquimod) Cream 5 percent for the treatment of actinic keratoses (AK) on the face or scalp in immunocompetent adults.
Incyte to Present Numerous Studies at EADV 2023
The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis
Prolonged Remission in Rosacea: A Breakthrough With Subantibiotic Dose of Oral Doxycycline
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
DEF and SDPA Partner to Emphasize Cardiovascular Health for World Heart Day
Discovering Dermatology Times: September 2023
2 Clarke Drive Cranbury, NJ 08512